<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9794238" created="06/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9794238</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Relationship between <term id="T1" lex="IkappaBalpha_constitutive_expression" sem="Other"><term id="T2" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> constitutive expression</term>, <term id="T3" lex="TNFalpha_synthesis" sem="Other"><term id="T4" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term> synthesis</term>, and apoptosis in <term id="T5" lex="EBV-infected_lymphoblastoid_cell" sem="Cell_natural"><term id="A1" sem="Virus">EBV</term>-infected <term id="A2" sem="Cell_natural">lymphoblastoid cells</term></term>.</sentence>
<event KT="Other" id="E1">
<type class="Gene_expression"/>
<theme idref="T2"/>
<clue>Relationship between IkappaBalpha constitutive <clueType>expression</clueType>, TNFalpha synthesis, and apoptosis in EBV-infected lymphoblastoid cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue>Relationship between IkappaBalpha constitutive expression, TNFalpha <clueType>synthesis</clueType>, and apoptosis <clueLoc>in EBV-infected lymphoblastoid cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E3">
<type class="Initiation_of_viral_infection"/>
<theme idref="A2"/>
<theme idref="A1"/>
<clue>Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and apoptosis in EBV-<clueType>infected</clueType> lymphoblastoid cells.</clue>
</event>
<event KT="Other" id="E31">
<type class="Cellular_physiological_process"/>
<theme idref="T5"/>
<clue>Relationship between IkappaBalpha constitutive expression, TNFalpha synthesis, and <clueType>apoptosis</clueType> <linkTheme>in</linkTheme> EBV-infected lymphoblastoid cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In order to understand the role of <term id="T6" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in <term id="A14" sem="Other"><term id="A3" sem="Virus">EBV</term> transformation</term> we have established stably transfected <term id="T7" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> into <term id="T8" lex="lymphoblastoid_cell" sem="Cell_natural">lymphoblastoid cells</term>.</sentence>
<event KT="Investigation" id="E4" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="T6"/>
<clue><clueKT>In order to understand</clueKT> the <clueType>role</clueType> <linkCause>of</linkCause> NF-kappaB <linkTheme>in</linkTheme> EBV transformation we have established stably transfected IkappaBalpha into lymphoblastoid cells.</clue>
</event>
<event KT="Other" id="E22">
<type class="Biological_process"/>
<theme idref="T8"/>
<clue>In order to understand the role of NF-kappaB in EBV <clueType>transformation</clueType> we have established stably transfected IkappaBalpha into lymphoblastoid cells.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="A3"/>
<clue>In order to understand the role of NF-kappaB in EBV <clueType>transformation</clueType> we have established stably transfected IkappaBalpha into lymphoblastoid cells.</clue>
</event>
<event KT="Other" id="E32">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue>In order to understand the role of NF-kappaB in EBV transformation we have established <clueType>stably transfected</clueType> IkappaBalpha <clueLoc>into lymphoblastoid cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<clue>In order to understand the role of NF-kappaB in EBV transformation we have established <clueType>stably transfected</clueType> IkappaBalpha <clueLoc>into lymphoblastoid cells</clueLoc>.</clue>
</event>
<sentence id="S3">Two clones were obtained in which the loss of <term id="T9" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity correlated with the <term id="T10" lex="constitutive_expression" sem="Other">constitutive expression</term> of the transgenic <term id="T11" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term>.</sentence>
<event KT="Other" id="E6">
<type class="Binding"/>
<theme idref="T9"/>
<clue>Two clones were obtained in which the loss <linkTheme>of</linkTheme> NF-kappaB <clueType>binding</clueType> activity correlated with the constitutive expression of the transgenic IkappaBalpha.</clue>
</event>
<event KT="Other" id="E11">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<clue>Two clones were obtained in which the <clueType>loss</clueType> <linkTheme>of</linkTheme> NF-kappaB binding activity correlated with the constitutive expression of the transgenic IkappaBalpha.</clue>
</event>
<event KT="Other" id="E7">
<type class="Gene_expression"/>
<theme idref="T11"/>
<clue>Two clones were obtained in which the loss of NF-kappaB binding activity correlated with the <clueType>constitutive expression</clueType> <linkTheme>of</linkTheme> the transgenic IkappaBalpha.</clue>
</event>
<event KT="Method" id="E34">
<type class="Artificial_process"/>
<theme idref="T11"/>
<clue>Two clones were obtained in which the loss of NF-kappaB binding activity correlated with the constitutive expression of the <clueType>transgenic</clueType> IkappaBalpha.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Correlation"/>
<theme idref="E6"/>
<theme idref="E7"/>
<clue><clueLoc>Two clones</clueLoc> were obtained in which the loss of NF-kappaB binding activity <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the constitutive expression of the transgenic IkappaBalpha.</clue>
</event>
<sentence id="S4"><term id="T12" lex="protein_latency_expression" sem="Other"><term id="A4" sem="Protein_family_or_group">Protein</term> latency expression</term> was determined by <term id="T13" lex="immunocytochemistry" sem="Other">immunocytochemistry</term>.</sentence>
<event KT="Analysis" id="E9" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A4"/>
<clue>Protein latency <clueType>expression</clueType> was <clueKT>determined</clueKT> <clueExperiment>by immunocytochemistry</clueExperiment>.</clue>
</event>
<sentence id="S5">Expression of <term id="A17" sem="Protein_family_or_group">surface markers</term>, <term id="T14" lex="intracytoplasmic_content" sem="Other">intracytoplasmic content</term> of <term id="T15" lex="cytokine" sem="Protein_family_or_group">cytokines</term> cell cycle analysis after <term id="T16" lex="BrdU_incorporation" sem="Other"><term id="T17" lex="BrdU" sem="Protein_molecule">BrdU</term> incorporation</term> and DNA staining with <term id="T18" lex="propidium_iodide" sem="Organic_compound_other">propidium iodide</term> were studied by <term id="T19" lex="flow_cytometry" sem="Other">flow cytometry</term>.</sentence>
<event KT="Investigation" id="E35" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A17"/>
<clue><clueType>Expression</clueType> <linkTheme>of</linkTheme> surface markers, intracytoplasmic content of cytokines cell cycle analysis after BrdU incorporation and DNA staining with propidium iodide were <clueKT>studied</clueKT> <clueExperiment>by flow cytometry</clueExperiment>.</clue>
</event>
<sentence id="S6">Percentage of <term id="T20" lex="apoptotic_cell" sem="Cell_natural">apoptotic cells</term> was determined by <term id="T21" lex="in-situ_labelling" sem="Other">in-situ labelling</term> of DNA strand breaks.</sentence>
<sentence id="S7">No significative changes in <term id="T22" lex="EBV" sem="Virus">EBV</term> latency nor in <term id="T23" lex="cell_surface_marker_expression" sem="Other"><term id="A6" sem="Protein_family_or_group">cell surface marker</term> expression</term> was found.</sentence>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E12">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<clue><cluePolarity>No</cluePolarity> <clueManner>significative</clueManner> <clueType>changes</clueType> <linkTheme>in</linkTheme> EBV latency nor in cell surface marker expression was <clueKT>found</clueKT>.</clue>
</event>
<event id="E21">
<type class="Viral_life_cycle"/>
<theme idref="T22"/>
<clue>No significative changes in EBV <clueType>latency</clueType> nor in cell surface marker expression was found.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E13">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<clue>No <clueManner>significative</clueManner> <clueType>changes</clueType> in EBV latency <cluePolarity>nor</cluePolarity> <linkTheme>in</linkTheme> cell surface marker expression was <clueKT>found</clueKT>.</clue>
</event>
<event id="E14">
<type class="Gene_expression"/>
<theme idref="A6"/>
<clue>No significative changes in EBV latency nor in cell surface marker <clueType>expression</clueType> was found.</clue>
</event>
<sentence id="S8">In contrast, <term id="T24" lex="intracytoplasmic_TNFalpha_level" sem="Other">intracytoplasmic <term id="A18" sem="Other"><term id="T25" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term> levels</term></term> were strongly reduced in <term id="T26" lex="transfected_clone" sem="Cell_cultured">transfected clones</term>.</sentence>
<event Manner="High" id="E15">
<type class="Negative_regulation"/>
<theme idref="A18"/>
<clue>In contrast, <clueLoc>intracytoplasmic</clueLoc> TNFalpha levels were <clueManner>strongly</clueManner> <clueType>reduced</clueType> <clueLoc>in transfected clones</clueLoc>.</clue>
</event>
<sentence id="S9">Furthermore, 30% of <term id="T27" lex="IkappaBalpha_transfected_cell" sem="Cell_cultured"><term id="T28" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> transfected cells</term> were apoptotic after 8 h of <term id="T29" lex="TNFalpha_treatment" sem="Other"><term id="T30" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term> treatment</term>.</sentence>
<event id="E38">
<type class="Gene_expression"/>
<theme idref="T28"/>
<clue>Furthermore, 30% of IkappaBalpha <clueType>transfected</clueType> <clueLoc>cells</clueLoc> were apoptotic after 8 h of TNFalpha treatment.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<clue>Furthermore, 30% of IkappaBalpha <clueType>transfected</clueType> <clueLoc>cells</clueLoc> were apoptotic after 8 h of TNFalpha treatment.</clue>
</event>
<event id="E18">
<type class="Cellular_physiological_process"/>
<theme idref="T27"/>
<clue>Furthermore, 30% of IkappaBalpha transfected cells were <clueType>apoptotic</clueType> after 8 h of TNFalpha treatment.</clue>
<comment>TPS: A27</comment></event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T30"/>
<clue>Furthermore, 30% of IkappaBalpha transfected cells were apoptotic <linkCause>after</linkCause> <clueTime>8 h</clueTime> <linkCause>of</linkCause> TNFalpha treatment.</clue>
</event>
<sentence id="S10">This correlated with a strong reduction of <term id="T31" lex="BrdU_incorporation" sem="Other"><term id="T32" lex="BrdU" sem="Nucleotide">BrdU</term> incorporation</term> after 24 h of <term id="T33" lex="TNFalpha_treatment" sem="Other"><term id="T34" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term> treatment</term>.</sentence>
<event KT="Analysis" id="E19">
<type class="Correlation"/>
<theme idref="E18"/>
<theme idref="E20"/>
<clue><corefTheme>This</corefTheme> <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> a strong reduction of <clueExperiment>BrdU incorporation</clueExperiment> after 24 h of TNFalpha treatment.</clue>
</event>
<event KT="Other" Manner="High" id="E20">
<type class="Negative_regulation"/>
<theme idref="T31"/>
<cause idref="T34"/>
<clue>This correlated with a <clueManner>strong</clueManner> <clueType>reduction</clueType> <linkTheme>of</linkTheme> BrdU incorporation <linkCause>after</linkCause> <clueTime>24 h</clueTime> of TNFalpha treatment.</clue>
</event>
<sentence id="S11">No effect was seen with non <term id="T35" lex="transfected_cell" sem="Cell_cultured">transfected cells</term> or with <term id="A15" sem="Cell_cultured"><term id="A9" sem="Cell_natural">cells</term> transfected with a <term id="A10" sem="DNA_family_or_group">control plasmid</term></term>.</sentence>
<event KT="Method" id="E23">
<type class="Artificial_process"/>
<theme idref="A9"/>
<theme idref="A10"/>
<clue>No effect was seen with non transfected cells or with cells <clueType>transfected</clueType> <linkTheme>with</linkTheme> a control plasmid.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Physiological_process"/>
<theme idref="T35"/>
<cause idref="T34"/>
<clue><cluePolarity>No</cluePolarity> <clueType>effect</clueType> was <clueKT>seen</clueKT> <linkTheme>with</linkTheme> <cluePolarity>non</cluePolarity> transfected cells or with cells transfected with a control plasmid.</clue>
<comment>NO COREFCAUSE; CAUTION, non-apoptotic</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Physiological_process"/>
<theme idref="A15"/>
<cause idref="T34"/>
<clue><cluePolarity>No</cluePolarity> <clueType>effect</clueType> was <clueKT>seen</clueKT> with non transfected cells or <linkTheme>with</linkTheme> cells transfected with a control plasmid.</clue>
<comment>NO COREFCAUSE; TPS: A15; CAUTION, non-apoptotic</comment></event>
<sentence id="S12">Our results suggest that the <term id="T36" lex="TNFalpha_gene" sem="DNA_domain_or_region"><term id="T37" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term> gene</term> could be one of the targets of <term id="T38" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in <term id="T39" lex="EBV" sem="Virus">EBV</term> infected <term id="A12" sem="Cell_natural">cells</term> and that <term id="T40" lex="NF-kappaB_protects_EBV-infected_cell" sem="Cell_natural"><term id="T41" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> protects <term id="A19" sem="Cell_cultured"><term id="T42" lex="EBV" sem="Virus">EBV</term>-infected <term id="A11" sem="Cell_natural">cells</term></term></term> from <term id="A16" sem="Other">apoptosis</term> induced by <term id="T43" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term>, which may favour the <term id="T44" lex="proliferative_effect" sem="Other">proliferative effect</term> of this <term id="T45" lex="cytokine" sem="Protein_family_or_group">cytokine</term>.</sentence>
<event CL="L1" KT="Analysis" id="E36" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T36"/>
<cause idref="T38"/>
<clue>Our results <clueKT>suggest</clueKT> that the TNFalpha gene <clueCL>could</clueCL> be one of the <clueType>targets</clueType> <linkCause>of</linkCause> NF-kappaB <clueLoc>in EBV infected cells</clueLoc> and that NF-kappaB protects EBV-infected cells from apoptosis induced by TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
<event KT="Other" id="E26">
<type class="Initiation_of_viral_infection"/>
<theme idref="A11"/>
<theme idref="T42"/>
<clue>Our results suggest that the TNFalpha gene could be one of the targets of NF-kappaB in EBV infected cells and that NF-kappaB protects EBV-<clueType>infected</clueType> cells from apoptosis induced by TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
<event KT="Other" id="E37">
<type class="Cellular_physiological_process"/>
<theme idref="A19"/>
<clue>Our results suggest that the TNFalpha gene could be one of the targets of NF-kappaB in EBV infected cells and that NF-kappaB protects EBV-infected cells from <clueType>apoptosis</clueType> induced by TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T43"/>
<clue>Our results suggest that the TNFalpha gene could be one of the targets of NF-kappaB in EBV infected cells and that NF-kappaB protects EBV-infected cells from apoptosis <clueType>induced</clueType> <linkCause>by</linkCause> TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
<event CL="L2" KT="Analysis" id="E28">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T41"/>
<clue>Our results <clueKT><clueCL>suggest</clueCL></clueKT> that the TNFalpha gene could be one of the targets of NF-kappaB in EBV infected cells and that NF-kappaB <clueType>protects</clueType> EBV-infected cells <linkTheme>from</linkTheme> apoptosis induced by TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
<event KT="Other" id="E29">
<type class="Initiation_of_viral_infection"/>
<theme idref="A12"/>
<theme idref="T39"/>
<clue>Our results suggest that the TNFalpha gene could be one of the targets of NF-kappaB in EBV <clueType>infected</clueType> cells and that NF-kappaB protects EBV-infected cells from apoptosis induced by TNFalpha, which may favour the proliferative effect of this cytokine.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
